A Comprehensive Toolkit for SARS-CoV-2 Research
To support the development of SARS-CoV-2 research, Sino Biological has developed a comprehensive toolkit, including recombinant antigens (N protein, S protein, S1, and S2 subunits of S protein, and RBD domain of S protein), antibodies, antigen detection kits and, genes. These reagents have supported hundreds of research groups around the globe for their vaccines, therapeutic antibodies and immunodiagnostic assays, and the basic research - over 200 research papers have cited these reagents that have been published in Cell, Nature, Science, etc.
For SARS-CoV-2 Antigen Tests:
SARS-CoV-2 antigen test relies on the immunodetection of the viral antigens in biological samples. The company has developed a panel of antibodies specific to SARS-CoV-2 S&N proteins and antibody pairs that can be used to assemble detection assays for the corresponding antigen.
SARS-CoV-2 Specific and Neutralizing Antibodies:
There are a large collection of antibodies against different antigens of SARS-CoV-2. These antibodies can be used to detect and/or neutralize the virus in a variety of assays including ELISA, western blot, Immunofluorescent staining, Immunohistochemistry, SPR (Biacore and Octet), psuedovirus infection, and potentially in vivo animal studies.
Viral Antigen Bank: ProVirTM:
Sino Biological officially announced the launch of the world’s largest viral antigen bank, ProVirTM. This unique portfolio includes the one-of-a-kind coronavirus catalog such as SARS-CoV-2, a huge collection of infleunza antigens, and many other hard-to-find viral proteins. These reagents are specifically developed to help vaccine research and drug development.
